Prices for drugs under shortage between 2015 and 2016 increased more than twice as quickly as they were expected to in the absence of a shortage. While researchers could not assess reasons for the increases, manufacturers were suspected of exploiting shortages to charge more for drugs in high demand. A brief research report is published in Annals of Internal Medicine.
Prescription drug shortages cause an estimated $230 million in additional costs each year because of the rising prices of drugs under shortage and the higher costs of substitution drugs. This public health crisis may require attention from policymakers.
Source: Read Full Article